v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jul. 04, 2026
Jan. 03, 2026
Current assets:    
Cash and cash equivalents $ 97,196 $ 193,260
Patient accounts receivable 337,233 313,358
Receivables under insured programs 3,754 2,758
Prepaid expenses 22,227 20,940
Other current assets 17,684 29,916
Total current assets 478,094 560,232
Property and equipment, net 18,442 16,653
Operating lease right of use assets 38,437 39,034
Goodwill 1,276,019 1,121,042
Intangible assets, net 99,820 92,559
Receivables under insured programs 38,343 28,806
Deferred income taxes 136,764 137,140
Other long-term assets 20,458 16,913
Total assets 2,106,377 2,012,379
Current liabilities:    
Accounts payable and other accrued liabilities 32,408 31,967
Accrued payroll and employee benefits 98,245 108,085
Current portion of insurance reserves - insured programs 3,754 2,758
Current portion of insurance reserves 19,912 17,154
Securitization obligations 165,000 165,000
Current portion of long-term obligations 13,250 13,250
Current portion of operating lease liabilities 16,443 16,012
Other current liabilities 62,312 70,230
Total current liabilities 411,324 424,456
Long-term obligations, less current portion 1,284,631 1,286,652
Long-term insurance reserves - insured programs 38,343 28,806
Long-term insurance reserves 58,106 49,061
Operating lease liabilities, less current portion 25,966 27,413
Other long-term liabilities 0 800
Total liabilities 1,818,370 1,817,188
Commitments and contingencies (Note 11)
Deferred restricted stock units 730 730
Stockholders' equity:    
Preferred stock, $0.01 par value as of July 4, 2026 and January 3, 2026 5,000,000 shares authorized; none issued or outstanding 0 0
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 217,510,046 and 210,996,359 issued and outstanding, respectively 2,182 2,110
Additional paid-in capital 1,360,278 1,349,480
Accumulated deficit (1,075,183) (1,157,129)
Total stockholders' equity 287,277 194,461
Total liabilities, deferred restricted stock units, and stockholders' equity $ 2,106,377 $ 2,012,379